The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies
出版年份 2021 全文链接
标题
The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-08-31
DOI
10.3389/fimmu.2021.728322
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia
- (2020) Peter A. A. Norris et al. HAEMATOLOGICA
- Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia
- (2020) Tadeusz Robak et al. Blood Advances
- Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies
- (2019) Mathilde Bas et al. JOURNAL OF IMMUNOLOGY
- Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
- (2019) James B. Bussel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
- (2019) James F. Howard et al. NEUROLOGY
- Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
- (2019) Kevin O. Saunders Frontiers in Immunology
- Next-generation Fc receptor–targeting biologics for autoimmune diseases
- (2019) Adrian W. Zuercher et al. AUTOIMMUNITY REVIEWS
- rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs
- (2018) Rolf Spirig et al. JOURNAL OF IMMUNOLOGY
- Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
- (2018) Peter Ulrichts et al. JOURNAL OF CLINICAL INVESTIGATION
- Kill ‘Em All: Efgartigimod Immunotherapy for Autoimmune Diseases
- (2018) Jagadeesh Bayry et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study
- (2018) Leona E. Ling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study
- (2017) Peter Kiessling et al. Science Translational Medicine
- Mechanisms of Autoantibody-Induced Pathology
- (2017) Ralf J. Ludwig et al. Frontiers in Immunology
- Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions
- (2017) O. S. Qureshi et al. Scientific Reports
- Targeting FcγRs to treat antibody-dependent autoimmunity
- (2016) Xiaojie Yu et al. AUTOIMMUNITY REVIEWS
- Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors
- (2016) Daniel F. Ortiz et al. Science Translational Medicine
- Intravenous immunoglobulin in neurology—mode of action and clinical efficacy
- (2015) Jan D. Lünemann et al. Nature Reviews Neurology
- Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity
- (2015) Nathaniel Washburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions
- (2015) Céline Monnet et al. Frontiers in Immunology
- Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis
- (2014) Muthusamy Thiruppathi et al. JOURNAL OF AUTOIMMUNITY
- Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or Basophils
- (2014) I. K. Campbell et al. JOURNAL OF IMMUNOLOGY
- Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody
- (2014) Céline Monnet et al. mAbs
- Beneficial effect of a multimerized immunoglobulin Fc in an animal model of inflammatory neuropathy (experimental autoimmune neuritis)
- (2013) Marzieh Niknami et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice
- (2012) Ajay Jain et al. ARTHRITIS RESEARCH & THERAPY
- Neonatal Fc Receptor Blockade by Fc Engineering Ameliorates Arthritis in a Murine Model
- (2011) D. A. Patel et al. JOURNAL OF IMMUNOLOGY
- Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
- (2011) Robert M. Anthony et al. NATURE
- Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
- (2008) A. Podolanczuk et al. BLOOD
- Fc receptors in immune thrombocytopenias: a target for immunomodulation?
- (2008) Bethan Psaila et al. JOURNAL OF CLINICAL INVESTIGATION
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
- (2008) R. M. Anthony et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now